Nijssen, David J. http://orcid.org/0000-0002-8360-8585
Wienholts, Kiedo http://orcid.org/0000-0002-3898-1663
Postma, Maarten J. http://orcid.org/0000-0002-6306-3653
Tuynman, Jurriaan http://orcid.org/0000-0001-5952-8000
Bemelman, Willem A. http://orcid.org/0000-0002-1037-9945
Laméris, Wytze
Hompes, Roel http://orcid.org/0000-0001-6094-8950
Funding for this research was provided by:
Stryker European Operations B.V
Article History
Received: 14 December 2023
Accepted: 3 April 2024
First Online: 20 May 2024
Declarations
:
: Stryker European Operations B.V. provided funding for conducting this study. R.H. receives grants and materials from Stryker European Operations B.V. and consultancy fees from Applied Medical. M.J.P. reports grants and honoraria from various pharmaceutical companies, all unrelated to this research; is an advisor of Asc Academics; and holds stocks from Health-Ecore and Pharmacoeconomics Advice Groningen. W.A.B. has received grants from Braun and Vifor, and has served as speaker for Takeda, Johnson and Johnson, and Braun. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Disclosure: the authors declare no other conflicts of interest.
: This study was preregistered in the independent, institutional registry PROSPERO (registration ID: CRD42022367453).
: We conducted a systematic literature review so we did not work with study participants and informed consent.